Outlook on the Artificial Tears Global Market to 2028 - by Type, Delivery Mode, Application and Geography
July 12, 2021 05:13 ET
|
Research and Markets
Dublin, July 12, 2021 (GLOBE NEWSWIRE) -- The "Artificial Tears Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Delivery Mode, and Application" report has been added to...
Dry Eye Disease Clinical Landscape Report 2021: Novartis Leads Industry Sponsors with the Highest Overall Number of Clinical Trials, Followed by AbbVie
July 08, 2021 07:08 ET
|
Research and Markets
Dublin, July 08, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Dry Eye Disease" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Systemic Lupus...
Outlook on the Dry Eye Disease (DED) Global Market to 2026 - Featuring Johnson & Johnson, Bausch Health and Alcon Among Others
April 29, 2021 05:13 ET
|
Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Global Dry Eye Disease (DED) Market - Analysis By Disease (Aqueous, Evaporative, Others), Treatment, End User, Distribution Channel, By Region, By...
Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference
November 13, 2020 19:35 ET
|
Tarsus Pharmaceuticals, Inc
IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (“Tarsus” NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver...
I-MED Pharma launches tearcheck® in Canada - A new standard in dry eye analysis
November 10, 2020 10:20 ET
|
I-MED Pharma
MONTREAL, Nov. 10, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announces the launch of tearcheck®, a new Health Canada approved...
I-MED Pharma Collaborates with KMG International to Supply PPE and Diagnostic Testing Products to Canada, USA & Europe
May 28, 2020 11:35 ET
|
I-MED Pharma
MONTREAL, May 28, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian medical device company, announced today that it is collaborating with KMG International Limited to manufacture and supply...
Patented IRPL® Technology Now Available in Canada!
April 27, 2020 10:48 ET
|
I-MED Pharma
MONTREAL, April 27, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is proud to announce Health Canada approval for the E>Eye...
I-MED Pharma to Launch Its Most Advanced Artificial Tear to Date With I-DROP® MGD
February 03, 2020 14:11 ET
|
I-MED Pharma
MONTREAL, Feb. 03, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the company has plans to launch its newest,...
Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
June 17, 2019 11:05 ET
|
I-MED Pharma
MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal Court of Appeal...
I-MED Pharma Celebrates 30 Years of Providing OSD & Surgical Solutions to the Global Eye Care Community
April 01, 2019 10:22 ET
|
I-MED Pharma
MONTREAL, April 01, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, proudly announces its 30-year anniversary providing OSD &...